Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cytomegalovirus immune globulin - Biotest

Next Previous
Search
Drug Profile

Cytomegalovirus immune globulin - Biotest

Alternative Names: BT-094; CMV-Gyn; CMVIG; Cytotect; Cytotect 70; Cytotect CP; Cytotect CP Biotest; Cytotect FH; HCMV-specific hyperimmune globulin - Biotest; Human cytomegalovirus immunoglobulin; Human normal immunoglobulin; Megalotect; Neocytotect

Latest Information Update: 20 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biotest
  • Developer Biotest AG
  • Class Antivirals; Immunoglobulins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cytomegalovirus infections
  • New Molecular Entity No

Highest Development Phases

  • Phase III Cytomegalovirus infections

Most Recent Events

  • 10 Mar 2025 Biotest terminates a phase III trial for Cytomegalovirus infections (Prevention) in Germany, due to sponsor decision (IV, Infusion) (EudraCT2020-002383-32) (NCT05170269)
  • 19 Dec 2024 Biotest completes a phase-II SYNTAGME trials in Cytomegalovirus infections (Prevention) in France (IV) (EudraCT2020-005582-13) (NCT04934527)
  • 13 Sep 2022 Biotest in collaboration with University Hospital initiates a phase II trial for Cytomegalovirus infections in France (NCT05370976)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top